Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multi-drug resistant HIV disease

Ahmed M Bayoumi, Paul G Barnett, Vilija R Joyce, Susan C Griffin, Huiying Sun, Nick J Bansback, Mark Holodniy, Gillian Sanders, Sheldon T Brown, Tassos C Kyriakides, Brian Angus, D William Cameron, Aslam H Anis, Mark Sculpher, Douglas K Owens

Research output: Contribution to journalArticlepeer-review

Abstract

Newer antiretroviral drugs provide substantial benefits but are expensive. We determined the cost-effectiveness of using antiretroviral drugs in combination for patients with multi-drug resistant HIV disease.
Original languageEnglish
Pages (from-to)382-391
Number of pages10
JournalJaids-Journal of acquired immune deficiency syndromes
Volume64
Issue number4
DOIs
Publication statusPublished - 1 Oct 2013

Cite this